Comparing Point of Care Clotting Tests in the OR Versus Standard Laboratory Clotting Tests
NCT ID: NCT00892905
Last Updated: 2011-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2008-01-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thrombin in Cardiac Surgery
NCT04762576
Thrombin Generation During Cardiopulmonary Bypass With Titrated Versus Conventional Anticoagulation Management.
NCT03347201
Diagnostic Accuracy Study of a Point-of-Care Test for Coagulation Function
NCT06037720
Heparin Dose and Post Operative Bleeding in Cardiopulmonary Bypass Patients
NCT01574105
Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass
NCT00587444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
POC INR and APTT Hemochron
Adult patients undergoing elective on pump coronary artery bypass grafting surgery who have not received anticoagulants or clopidogrel within 5 days preoperatively.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* heparin resistance
* receiving heparin or warfarin
* hepatic or renal dysfunction
* pregnancy
* urgent or emergency cases
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamilton Health Sciences Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hamilton Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Summer Syed, MD
Role: PRINCIPAL_INVESTIGATOR
Hamilton Health Sciences Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamilton General Hospital
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-467
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.